Mackenzie Financial Corp Anika Therapeutics, Inc. Transaction History
Mackenzie Financial Corp
- $71.1 Billion
- Q4 2024
A detailed history of Mackenzie Financial Corp transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 14,048 shares of ANIK stock, worth $249,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,048Holding current value
$249,352% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIK
# of Institutions
110Shares Held
11.1MCall Options Held
1.8KPut Options Held
1.9K-
Trigran Investments, Inc.2.02MShares$35.9 Million4.19% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$28.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA765KShares$13.6 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY700KShares$12.4 Million3.96% of portfolio
-
Dimensional Fund Advisors LP Austin, TX657KShares$11.7 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $259M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...